RESUMO
Host modulation therapy is recently employed to improve periodontal treatments outcome. This randomized controlled clinical trial aimed to evaluate the effects of Semelil (ANGIPARS) as an adjunct to non-surgical treatment in patients with chronic periodontitis. Forty-four healthy subjects with moderate to severe chronic periodontitis were enrolled in the study. After completion of phase I periodontal therapy, including oral hygiene instruction, scaling, and root planing, the patients were randomly divided into two groups to receive capsules of Semelil (test) or placebo (control), consuming two capsules a day for three months. Clinical parameters (probing depth [PD], clinical attachment level [CAL], modified sulcular bleeding index [MSBI], modified gingival index [MGI], and plaque index [PI]) and biochemical parameters (interleukin-1ß [IL-1ß], 8-hydroxy-2-deoxyguanosine [8-OHdG]), and lipid peroxidation [LPO]) were measured at baseline and after completion of treatment. Twenty-five patients completed the study: 15 in the test group and 10 in the control group. All clinical and biochemical parameters were significantly improved from baseline to the final measurements in both groups (p < 0.001). The changes were more pronounced in the test group in comparison to the control group. However, the differences between the groups were significant only for MGI, MSBI, PD, and CAL (p < 0.05). Semelil may reveal promising results as an adjunctive treatment for chronic periodontitis.
RESUMO
PURPOSE: To evaluate the neurocompatibility of different types of dental implant surface treatments using the P19 neural cell line. MATERIALS AND METHODS: P19 cells were plated and supplemented with retinoic acid to grow as aggregates for 4 days. Twenty dental implants were selected from four different implant systems with five different surface treatments. The implants were divided into four groups (n=5), placed inside medical rings, and fixed by injection of warm gutta-percha using a thermoplastic injection technique. Implant molds were placed inside graded culture dishes, and culture medium containing P19 neural cells were plated on the dishes for 4 days. After 24 hours, the surfaces of the implant molds were covered with self-curing resin to make a replica of each mold surface. Replicas were assessed under a scanning electron microscope, and the number of cells and the total cells covering the areas were evaluated. Data were analyzed by a post hoc Tukey test. RESULTS: There were significant differences in P19 cell counts between all modified and electropolished surfaces. The highest P19 cell counts were shown on OsseoSpeed and Laser-Lok surfaces. The lowest counts were shown on the Nanotite surface at the collar. OsseoSpeed and Laser-Lok surfaces showed higher counts at the collar than on the body; the opposite was seen for SLActive and Nanotite surfaces. Cell-covered areas on Laser-Lok surfaces showed significantly higher values than the resorbable blasted media (RBM)-treated surfaces, while it was not significantly different from the OsseoSpeed surface of collar regions. SLActive collar regions showed larger cell-covered areas than the SLActive body surfaces, but this was not significant. CONCLUSIONS: All test surface treatments in this study showed better neurocompatibility than control group surfaces. The Laser-Lok, RBM, and OsseoSpeed surfaces were superior to the Nanotite and SLActive surfaces in terms of neurocompatibility.